Tango Therapeutics files amended 8-K on executive chair transition
TNGX•Amended 8-K updates leadership change disclosure
Tango Therapeutics filed an amended Form 8-K to update disclosure on a leadership change.
- Executive Chair Barbara Weber will step down from the board in connection with other pursuits.
- The amendment frames the transition as a governance change with no financial terms disclosed.
